Stocks in News: Sun Pharma, Tata Motors, and Voltas Lead Key Moves
Indian markets ended their five-session winning streak on Friday, closing lower as a broad-based sell-off in the IT sector weighed heavily on sentiment. While the Nifty faced resistance near the 24,150 zone, several individual stocks including Sun Pharma, Tata Motors, and Voltas grabbed investor attention due to significant corporate developments.
Sun Pharma and Alembic Pharma Strengthen Healthcare Portfolios
India’s largest drugmaker, Sun Pharmaceutical Industries Ltd, is set to bolster its product portfolio through a strategic acquisition. The company has agreed to acquire Mumbai-based Innovcare Lifesciences Private Ltd in an all-cash deal valued at approximately $28.7 million (roughly Rs 271.2 crore).
In a similar vein of expansion, Alembic Pharmaceuticals Ltd received positive news from international regulators. The company announced it has received tentative approval from US health authorities for its generic version of Binimetinib tablets, a critical cancer treatment drug, marking a significant step in its US market penetration.
Tata Motors and Voltas Capitalize on Domestic Demand
The automotive and consumer durables sectors showed strong momentum through recent performance metrics. Tata Motors has successfully secured over 3,400 orders for its electric commercial vehicles (eCVs). These orders span across the freight, logistics, and passenger mobility segments, signaling a robust transition toward electric mobility among Indian commercial fleet operators.
Voltas, a Tata Group company and leader in the room air conditioner (RAC) market, reported a major sales milestone. The company crossed the one-million-unit mark within the first three months of the 2026-27 financial year. Achieving this in record time underscores Voltas's dominant position in the Indian cooling segment.
Strategic Shifts at ONGC and Tech Mahindra’s Expansion
Energy giant ONGC is undergoing a fundamental strategic repositioning. Chairman and CEO Arun Kumar Singh indicated that the company is transitioning its identity to be viewed as a "gas and oil" firm rather than an "oil and gas" company, emphasizing a renewed focus on gas-led energy production.
Meanwhile, in the technology sector, Tech Mahindra is doubling down on its operational footprint. The firm has secured nearly 4 lakh sq ft of office space on a long-term lease in Hyderabad. This transaction stands as one of the largest office leasing deals in the city this year, reflecting the sustained demand for premium workspace among major technology occupiers.
FMCG and Infrastructure Growth Plans
The FMCG sector saw movement from Jyothy Labs, which is expanding its Exo brand into a broader dishwash franchise following the exit of Henkel AG & Co. KGaA from its licensing arrangements for Pril and Fa brands. On the infrastructure front, Dalmia Bharat announced aggressive expansion plans, aiming to raise up to Rs 4,000 crore to scale its manufacturing capacity to 110–130 million tonnes per annum by FY31 through various acquisition and greenfield projects.
Key Takeaways
- Strategic M&A: Sun Pharma is expanding its reach via a $28.7 million cash acquisition of Innovcare Lifesciences.
- Sectoral Milestones: Voltas achieved a record 1 million RAC sales in just three months, while Tata Motors secured 3,400+ eCV orders.
- Energy Pivot: ONGC is shifting its core strategic focus toward gas-centric energy production.